Clinical trial
High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer
NCT03007875
Study timeline
Study start (actual)2016-12-01Date precision: day
Registry last updated2019-09-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancer Metastaticunresolved
Interventions
high-activity natural killerBIOLOGICAL
Sponsors & collaborators
Fuda Cancer Hospital, Guangzhoulead sponsor
Shenzhen Hank Bioengineering Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03007875 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.